Michael R Hayden Insider Trading $XENE Xenon Pharmaceuticals Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Michael R Hayden.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Michael R Hayden. Michael R Hayden is Director in IONIS PHARMACEUTICALS INC ($ISIS) and Director in Xenon Pharmaceuticals Inc. ($XENE) and Director in Aurinia Pharmaceuticals Inc. ($AUPH) and Director in AbCellera Biologics Inc. ($ABCL) and Director in 89bio, Inc. ($ETNB).

Michael R Hayden in Xenon Pharmaceuticals Inc.

Trading Symbol: XENE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael R Hayden: Director
Holdings: 50,924 shares
Current Value: $417,577
Latest Transaction: Jun 02 2020
$XENE Market Capitalization: $145.83M
$XENE Previous Close: $8.20

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Michael R Hayden in Xenon Pharmaceuticals Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ETNB, ABCL, AUPH, ISIS, XENE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 02 2020XENEXenon Pharmaceutic ...Hayden Michael RDirectorOption ExerciseA13.1110,000131,10010,000
Sep 18 2019XENEXenon Pharmaceutic ...Hayden Michael RDirectorOption ExerciseA9.4415,000141,60015,000
Mar 20 2019XENEXenon Pharmaceutic ...Hayden Michael RDirectorOption ExerciseM3.3820,57669,5470
Mar 20 2019XENEXenon Pharmaceutic ...Hayden Michael RDirectorBuyM3.3820,57669,54750,92430.3 K to 50.9 K (+67.80 %)
Mar 12 2019XENEXenon Pharmaceutic ...Hayden Michael RDirectorGiftG0.0017,3370114,40397.1 K to 114.4 K (+17.86 %)
Mar 12 2019XENEXenon Pharmaceutic ...Hayden Michael RDirectorGiftG0.0024,0450107,562131.6 K to 107.6 K (-18.27 %)
Jun 05 2018XENEXenon Pharmaceutic ...Hayden Michael RDirectorOption ExerciseA6.2015,00093,00015,000
Mar 01 2018XENEXenon Pharmaceutic ...Hayden Michael RDirectorGiftG0.0021,180097,06675.9 K to 97.1 K (+27.91 %)
Mar 01 2018XENEXenon Pharmaceutic ...Hayden Michael RDirectorGiftG0.0029,5800131,607161.2 K to 131.6 K (-18.35 %)
Aug 14 2017XENEXenon Pharmaceutic ...Hayden Michael RDirectorBuyP2.7515,00041,247161,187146.2 K to 161.2 K (+10.26 %)
Jun 02 2017XENEXenon Pharmaceutic ...Hayden Michael RDirectorOption ExerciseA3.853,50013,4753,500
Mar 15 2017XENEXenon Pharmaceutic ...Hayden Michael RDirectorOption ExerciseM3.563,08610,9860
Mar 15 2017XENEXenon Pharmaceutic ...Hayden Michael RDirectorOption ExerciseM3.074,62914,2110
Mar 15 2017XENEXenon Pharmaceutic ...Hayden Michael RDirectorOption ExerciseM3.774,11515,5140
Mar 15 2017XENEXenon Pharmaceutic ...Hayden Michael RDirectorOption ExerciseM3.675,14418,8780
Mar 15 2017XENEXenon Pharmaceutic ...Hayden Michael RDirectorOption ExerciseM3.7625,72096,7070
Mar 15 2017XENEXenon Pharmaceutic ...Hayden Michael RDirectorOption ExerciseM3.7018,00466,6150
Mar 15 2017XENEXenon Pharmaceutic ...Hayden Michael RDirectorBuyM3.563,08610,98630,34827.3 K to 30.3 K (+11.32 %)
Mar 15 2017XENEXenon Pharmaceutic ...Hayden Michael RDirectorBuyM3.074,62914,21127,26222.6 K to 27.3 K (+20.45 %)
Mar 15 2017XENEXenon Pharmaceutic ...Hayden Michael RDirectorBuyM3.774,11515,51422,63318.5 K to 22.6 K (+22.22 %)
Mar 15 2017XENEXenon Pharmaceutic ...Hayden Michael RDirectorBuyM3.675,14418,878146,187141 K to 146.2 K (+3.65 %)
Mar 15 2017XENEXenon Pharmaceutic ...Hayden Michael RDirectorBuyM3.7625,72096,707141,043115.3 K to 141 K (+22.30 %)
Mar 15 2017XENEXenon Pharmaceutic ...Hayden Michael RDirectorBuyM3.7018,00466,615115,32397.3 K to 115.3 K (+18.50 %)
Jun 03 2016XENEXenon Pharmaceutic ...Hayden Michael RDirectorOption ExerciseA7.383,50025,8303,500
May 27 2016XENEXenon Pharmaceutic ...Hayden Michael RDirectorOption ExerciseM3.308,23027,1590
May 27 2016XENEXenon Pharmaceutic ...Hayden Michael RDirectorBuyM3.308,23027,15918,51810.3 K to 18.5 K (+80.00 %)
May 06 2015XENEXenon Pharmaceutic ...Hayden Michael RDirectorOption ExerciseA13.483,08641,5993,086
Nov 12 2014XENEXenon Pharmaceutic ...Hayden Michael RDirectorOption ExerciseC0.001,50400
Nov 12 2014XENEXenon Pharmaceutic ...Hayden Michael RDirectorOption ExerciseC0.002,69300
Nov 12 2014XENEXenon Pharmaceutic ...Hayden Michael RDirectorOption ExerciseC0.0010,03000
Nov 12 2014XENEXenon Pharmaceutic ...Hayden Michael RDirectorBuyC0.001,504075,88674.4 K to 75.9 K (+2.02 %)
Nov 12 2014XENEXenon Pharmaceutic ...Hayden Michael RDirectorBuyC0.002,693074,38271.7 K to 74.4 K (+3.76 %)
Nov 12 2014XENEXenon Pharmaceutic ...Hayden Michael RDirectorBuyC0.0010,030071,68961.7 K to 71.7 K (+16.27 %)
Nov 06 2014XENEXenon Pharmaceutic ...Hayden Michael RDirectorOption ExerciseA9.005,14446,2965,144

Page:   1